– Company Developing Support Program for Current HVAD Patients – Medtronic Coordinating with Global Regulators to Assure Patient Access to Left Ventricular Assist Devices DUBLIN, June 3, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, is stopping the distribution […]
Tag: HVAD
FDA Alerts Health Care Providers to Stop New Implants of Certain Ventricular Assist Device System
SILVER SPRING, Md., June 3, 2021 /PRNewswire/ — The U.S. Food and Drug Administration is alerting health care providers to no longer implant end-stage heart failure patients with Medtronic’s Heartware Ventricular Assist Device (HVAD) System due to a growing body of observational clinical comparisons […]
Medtronic HeartWare(TM) HVAD(TM) System Approved for Destination Therapy
DUBLIN – September 27, 2017 – Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for its HeartWare(TM) HVAD(TM) System as a destination therapy for patients with advanced heart failure who are not candidates for heart transplants. […]
Recent
DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care
BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS
Lucia Health Guidelines Initiates Clinical Study Evaluating its Lucia Health Coach Generative AI Agent for Educating and Supporting Patients with Atrial Fibrillation
Popular
- No commented posts yet